NSE · SUNPHARMA.NS
Sun Pharmaceutical Industries Limited
₹1,812.40+₹51.40 (+2.92%)
Sun Pharmaceutical Industries Limited’s quoted price sits in the lower half of its reported 52-week range, 11.48% below the high.
Loading market information…
NSE · LYKALABS.NS · INR
Stock price, dividends, earnings
Quote as of Oct 30, 2026, 05:44 AM UTC. Cached market data; not a live quote.
One-year closing-price history · INR. Historical prices are not a forecast.
Lyka Labs Limited’s quoted price sits in the upper half of its reported 52-week range, 20.92% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
THE INCOME SIDE
Lyka Labs Limited’s forward annual dividend is ₹2.50 per share, paid annual. The forward yield is 3.22% at the quoted price. Future payments can change.
Historical amounts are adjusted for stock splits. Understand ex-dividend and payment dates →
Completed calendar years and any current-year payments shown separately. Current-year totals are incomplete until all payments are made.
See annual income at the current dividend rate.
Assumes the annual dividend stays unchanged. Payments follow the company’s schedule. Excludes taxes, fees and currency changes.
BEHIND THE RESULTS
Upcoming dates and analyst estimates may change. Fiscal quarters follow Lyka Labs Limited’s reporting calendar.
THE COMPANY BEHIND THE TICKER
Established in 1976 and headquartered in Mumbai, India, Lyka Labs Limited is a pharmaceutical firm specializing in the development, manufacturing, and marketing of a wide array of pharmaceutical formulations and active pharmaceutical ingredients (APIs). The company's extensive product portfolio addresses numerous therapeutic areas, including intensive care, gastroenterology, anti-infectives, anti-fungals, surgery, urology, wound care, anesthesia, and various dermatological and cosmeceutical applications like topical steroids, anti-acne, anti-aging, and hair care. These products are available in diverse forms, such as injections, creams, ointments, gels, and lotions. Beyond its own offerings, Lyka Labs also provides contract manufacturing services to other major pharmaceutical companies and offers comprehensive medical and technical support. This support includes manufacturing expertise, facility assistance, and crucial technical data such as molecule stability testing, impurity profiling, and bioequivalence (BA/BE) clinical study data. The company's market reach extends globally, with exports to various countries including Bangladesh, Cambodia, Congo, Costa Rica, Peru, Romania, Russia, Sri Lanka, Sudan, Ukraine, Venezuela, and Vietnam.
Latest available per-share figures in INR. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 07:21 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
₹1,812.40+₹51.40 (+2.92%)
Sun Pharmaceutical Industries Limited’s quoted price sits in the lower half of its reported 52-week range, 11.48% below the high.
₹448.50-₹8.50 (-1.86%)
Bafna Pharmaceuticals Limited’s quoted price sits in the upper half of its reported 52-week range, 6.55% below the high.
₹136.08-₹0.46 (-0.34%)
ZIM Laboratories Limited’s quoted price sits in the upper half of its reported 52-week range, 14.85% below the high.
₹418.35-₹12.30 (-2.86%)
Trident Lifeline Limited’s quoted price sits in the upper half of its reported 52-week range, 4.46% below the high.
₹1,389.20-₹40.00 (-2.8%)
Haleos Labs Limited’s quoted price sits in the lower half of its reported 52-week range, 21.69% below the high.
₹1,299.00+₹10.50 (+0.81%)
SMS Lifesciences India Limited’s quoted price sits in the lower half of its reported 52-week range, 22.68% below the high.
₹10.13-₹0.20 (-1.94%)
Nectar Lifesciences Limited’s quoted price sits in the lower half of its reported 52-week range, 55.04% below the high.
₹10.92-₹0.14 (-1.27%)
TAKE Solutions Limited’s quoted price sits in the lower half of its reported 52-week range, 78.22% below the high.
